Associate Director, Global Epidemiology
Janssen Research & Development LLC.
Tianyi (Tina) Wang, PhD, Associate Director, Janssen Research & Development LLC.
Tina is a cancer epidemiologist with >10 years of combined experience in pharmaceutical industry, academia, and clinical research settings. Tina designs studies that assess therapeutic safety and efficacy of cancer products using real-world data. Serving as a key member of the Diversity Equity Inclusion in Clinical Trials team, she plays a crucial role in developing diversity plans to mitigate health disparities in clinical trial recruitment. This includes the establishment of precise target enrollment goals for each underrepresented racial and ethnic group, employing a robust and evidence-based approach to enhance equity in clinical research. Before joining Johnson & Johnson, she was a research scientist at Moffitt Cancer Center, with primary focus on identifying innovative cancer risk factors and biomarkers, as well as developing novel cancer screening and early detection strategies, leveraging both population-based studies and real-world evidence.